Fresh analysis indicates that individuals who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who halt conventional lifestyle regimens.
Published data in a major health publication demonstrates that while overweight individuals often shed substantial amounts of their body weight while using the jabs, the mass returns at an average rate of 0.8 kg per month upon discontinuation.
"Individuals buying such medications should be informed of the danger of fast rebound weight gain when the treatment ends," stated expert Dr. Susan Jebb.
This pace of recovery implies a reversion to starting weight in about one and a half years.
Analyzing Therapies
The research, which looked at dozens of studies involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with other pills.
The team point out that people who lose weight through diet and exercise generally experience a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Quick Rebound
Nutrition scientists propose the mechanism of the injections accounts for the amplified regain.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication leads to appetite is uncontrolled, making binge eating much more probable."
An Ongoing Condition?
Medical guidelines suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, considering the likelihood of weight regain, the therapy is often long-term.
This view is supported by drug manufacturers, who say that the findings "emphasize the long-term nature of excess weight," akin to managing conditions like diabetes.
Patient Experiences
Users who have come off the medication describe a intense return of hunger.
"It felt as if something activating and you become ravenous," recalled a patient.
This challenge is worsened if individuals have not established lasting lifestyle or habit changes during therapy.
Widespread Use
Figures indicate that millions of adults in the UK have tried these injections in the past year, with demand remaining high.
- Adoption is greater among women compared to males.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians caution that while GLP-1 drugs are effective tools for weight loss, they are not a permanent cure and lasting health benefits hinges on combined lifestyle management.
